Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-03

Clinical Trial Update: The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction

View source ↗

Summary

A completed Novo Nordisk-sponsored trial evaluating how initiating or switching to insulin detemir affects emotional well-being and treatment satisfaction in pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED